HRT Financial’s Centessa Pharmaceuticals CNTA Stock Holding History

HRT Financial’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-116,992	Closed	-$4.65M	–	4355
2026 Q1	$4.65M	Buy	116,992 +105,972	+962%	+$2.71M	0.01%	1047
2025 Q4	$275K	Buy	+11,020	New	+$279K	﹤0.01%	2425

HRT Financial's CNTA Position: Q2 2026 in Review

HRT Financial sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 116,992 shares — an estimated $4.65M sold.

HRT Financial first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $4.65M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

HRT Financial reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 116,992 Centessa Pharmaceuticals shares in Q2 2026, an estimated $4.65M.
HRT Financial first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
HRT Financial's Centessa Pharmaceuticals position peaked at $4.65M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.